Vol. 14 Issue 1

This issue sponsored by the Southwest Lipid Association Featuring: "Why Advocacy is Important to a Medical Specialty Organization" and "Beyond the Guidelines: Application of Trial Data to Individual Patients by Focusing on Explanatory vs Pragmatic Trials" more

0
No votes yet

A passionate supporter of the National Lipid Association (NLA) and an advocate of clinical lipidology, Elizabeth (Beth) Jackson is a woman of many talents. Jackson works as a clinical nurse specialist and clinical lipid specialist with Edward R. Chafizadeh, MD, at CardioTexas in Austin, Texas. Some... more

0
No votes yet

Happy New Year from the Foundation of the National Lipid Association! We are hard at work ensuring that 2016 is as much of a success as 2015. Part of that success stems from the many fundraising events sponsored by the Foundation. We are pleased to announce the first Foundation event of the year... more

0
No votes yet

How many of you have taken the time to read, from front to back, the recent National Lipid Association (NLA) Recommendations for Patient-Centered Management of Dyslipidemia, Parts 1 and 2? Don’t be embarrassed, because I can’t see how few of you raised your hands. I had the good fortune to co-... more

0
No votes yet

“If you would not be forgotten as soon as you are dead and rotten, either write things worth reading or do things worth the writing.” – Benjamin Franklin The National Lipid Association is the premier organization dedicated to advancing our knowledge about the optimal approach to diagnosing and... more

0
No votes yet

I’ve been through many stages with the guidelines. I really think I love them now. Let me tell you why. I began my internal medicine residency in 1994, and the first time I ever heard that there was such a thing as guidelines, was at residents’ clinic in my first year where I was treating a man... more

0
No votes yet

In the strictest sense, “advocacy” is defined as the act or process of supporting a cause. With that as the basis of our discussion, why is advocacy important to a medical specialty organization such as the National Lipid Association (NLA)? The NLA’s mission statement includes comments on... more

0
No votes yet

Every 39 seconds, a U.S. adult dies from cardiovascular disease (CVD),1  the nation’s top killer and a leading cause of disability for Americans both young and old. We spend about 1 out of 6 healthcare dollars on this disease each year — an estimated nearly $320 billion in healthcare expenses... more

0
No votes yet

This edition of the LipidSpin is devoted to guidelines vs. guidance. We all strive to practice evidence-based medicine (EBM) and our understanding of science has moved forward at a quick pace. Multiple journals come out every week with new articles that advance medicine’s knowledge base. Large,... more

0
No votes yet

The American College of Cardiology/American Heart Association (ACC/AHA) Blood Cholesterol Guideline recommends high-intensity statin therapy for high-risk patients to reduce the risk of major adverse cardiovascular events (MACE).1 Despite treatment with high-intensity statins, patients... more

0
No votes yet

Back to all Lipid Spin